WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2012112160) COMPOSITIONS AND METHODS OF USE FOR DETERMINATION OF HE4A
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2012/112160    International Application No.:    PCT/US2011/025321
Publication Date: 23.08.2012 International Filing Date: 17.02.2011
IPC:
C12P 21/04 (2006.01), C12N 5/16 (2006.01)
Applicants: FUJIREBIO DIAGNOSTICS, INC [US/US]; 201 Great Valley Parkway Malvern, PA 19355-1308 (US) (For All Designated States Except US).
HELLSTROM, Ingegerd [US/US]; (US) (For US Only).
HELLSTROM, Karl-erik [US/US]; (US) (For US Only).
RAYCROFT, John; (For US Only).
FERMER, Christian [--/SE]; (SE) (For US Only).
ROIJER, Eva [--/SE]; (SE) (For US Only)
Inventors: HELLSTROM, Ingegerd; (US).
HELLSTROM, Karl-erik; (US).
RAYCROFT, John; .
FERMER, Christian; (SE).
ROIJER, Eva; (SE)
Agent: BENNETT-PARIS, Joseph, M.; Duane Morris LLP 1180 West Peachtree Street Suite 700 Atlanta, GA 30309-3448 (US)
Priority Data:
Title (EN) COMPOSITIONS AND METHODS OF USE FOR DETERMINATION OF HE4A
(FR) COMPOSITIONS ET MÉTHODES D'UTILISATION POUR LA DÉTERMINATION DE HE4A
Abstract: front page image
(EN)The invention includes the use of the HE/HE4a markers to assess ovarian cancer in a subject. Included also are compositions and methods of using HE/HE4a marker for diagnosis, grading and staging of ovarian cancers, determining prognosis and treatment effectiveness of a subject who has been diagnosed with ovarian cancer.
(FR)La présente invention a pour objet l'utilisation des marqueurs HE/HE4a pour évaluer le cancer de l'ovaire chez un sujet. La présente invention concerne également des compositions et des méthodes d'utilisation du marqueur HE/HE4a pour le diagnostic, la classification histologique et la stadification des cancers de l'ovaire, la détermination de l'efficacité du pronostic et du traitement d'un sujet chez qui on a diagnostiqué un cancer de l'ovaire.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)